NO20092359L - Aminoalkoholderivater og deres terapeutiske anvendelse - Google Patents

Aminoalkoholderivater og deres terapeutiske anvendelse

Info

Publication number
NO20092359L
NO20092359L NO20092359A NO20092359A NO20092359L NO 20092359 L NO20092359 L NO 20092359L NO 20092359 A NO20092359 A NO 20092359A NO 20092359 A NO20092359 A NO 20092359A NO 20092359 L NO20092359 L NO 20092359L
Authority
NO
Norway
Prior art keywords
alkyl
ring
ch2oh
optionally substituted
ch2or6
Prior art date
Application number
NO20092359A
Other languages
English (en)
Inventor
Andrea Walmsley
Elena Lasterra
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20092359L publication Critical patent/NO20092359L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)

Abstract

Forbindelse med formel (1): (1) omfattende farmasøytisk akseptable salter derav, hvor R1 er aryl eller heteroaryl eventuelt substituert med R8; R2 er H eller alkyl eller CH2 (når den utgjør en del av en ring med R3, R4 eller R5); R3 er H, alkyl, CH2OH eller CH2OR6 og kan være del av en ring med R2; R4 er H, alkyl, CH2OH eller CH2OR6 og kan være del av en ring med R2; R5 er H, alkyl, CH2OH eller CH2OR6 og kan være del av en ring med R2; R6 er H, alkyl, COH, COOR9, CON(R9)2, COR9, COR10, COR11, P(O)nR9, P(O)nR10, S(O)nR10 eller S(O)nR9 og kan være del av en ring med R2, R3, R4 eller R5; R7 er H, alkyl, COOR9, COOR11, COR9 eller CON(R9)2 og kan være del av en ring med R2, R3, R4, R5 eller R6; R8 er alkyl, CF3, OR9, OCOR9, CONH2, CN, F, Cl, Br, I, N(R9)2, NO2, NHCHO, NHCONH2, NHSO2R9, CON(R9)2, S(O)nR9, CH2OH eller OCON(R9)2; R9 er H, alkyl eller cykloalkyl; R10 er aryl eller heteroaryl (eventuelt substituert med R8) eller en fire- til syv-leddet ring (som eventuelt er substituert med R8 og kan inneholde ett eller flere ytterligere heteroatomer valgt fra listen over O, S(O)n og NR9); R11 er alkyl eventuelt substituert med R8 eller R10; og n er 0, 1 eller 2; forutsatt at når R3, R4 eller R5 er CH2OH, så er R6 ikke H, og at når R7 er H og R3, R4 og R5 er alkyl, så er R6 ikke H. Er av terapeutisk nytte ved behandling av en lidelse forbundet med T-celleproliferasjon, eller som blir mediert av pro- og/eller anti-inflammatoriske cytokiner.
NO20092359A 2006-12-12 2009-06-19 Aminoalkoholderivater og deres terapeutiske anvendelse NO20092359L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0624757.1A GB0624757D0 (en) 2006-12-12 2006-12-12 Novel compounds
PCT/GB2007/004752 WO2008071948A2 (en) 2006-12-12 2007-12-12 Aminoalcohol derivatives and their therapeutic use

Publications (1)

Publication Number Publication Date
NO20092359L true NO20092359L (no) 2009-07-08

Family

ID=37711970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092359A NO20092359L (no) 2006-12-12 2009-06-19 Aminoalkoholderivater og deres terapeutiske anvendelse

Country Status (14)

Country Link
US (1) US20100076068A1 (no)
EP (2) EP2118050A2 (no)
JP (1) JP5225287B2 (no)
KR (1) KR20090088442A (no)
CN (1) CN101573325A (no)
AU (1) AU2007331337A1 (no)
BR (1) BRPI0720284A2 (no)
CA (1) CA2672238A1 (no)
GB (1) GB0624757D0 (no)
IL (1) IL199178A0 (no)
MX (1) MX2009006246A (no)
NO (1) NO20092359L (no)
WO (1) WO2008071948A2 (no)
ZA (1) ZA200903942B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102635931B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 가려움증의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH246387A (de) * 1945-06-12 1946-12-31 H Dr Herzog Verfahren zur Herstellung eines Ephedrinderivates.
US2900415A (en) * 1954-12-14 1959-08-18 Lakeside Lab Inc Synthesized antispasmodic compounds
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
JPS609713B2 (ja) * 1976-10-08 1985-03-12 大塚製薬株式会社 カルボスチリル誘導体
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
DE2817494A1 (de) * 1977-05-03 1978-11-09 Continental Pharma Aminoalkohol-derivat
US4638070A (en) * 1978-12-21 1987-01-20 Continental Pharma Heterocyclic amino-alcohol derivatives
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
FR2555576B1 (fr) * 1983-11-25 1986-06-13 Lafon Labor Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation
IT1222986B (it) * 1987-10-23 1990-09-12 Texcontor Ets Derivati dell'efedrina esterificata aventi attivita' antiulcera prolungata nel tempo
WO1992003131A1 (en) * 1990-08-13 1992-03-05 G.D. Searle & Co. Use of heterocyclic amino-alcohol compounds for treatment of cns diseases
US5264459A (en) * 1992-07-13 1993-11-23 Arch Development Corporation Use of β-adrenergic agonists to treat patients with demyelinating or autoimmune diseases
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6646135B1 (en) * 1999-06-23 2003-11-11 Roche Vitamins Inc. Continuous process for the enantioselective hydrogenation of alpha ketocarbonyl compounds
US6560347B2 (en) * 2000-12-19 2003-05-06 Samsung Electro-Mechanics Co., Ltd. Multi actuator
US20040002546A1 (en) * 2001-09-15 2004-01-01 Eric Altschuler Methods for treating crohn's and other TNF associated diseases
AU2005281495A1 (en) 2004-09-07 2006-03-16 Sosei R & D Ltd. The treatment of inflammatory disorders and pain
IL166149A0 (en) * 2005-01-05 2006-01-15 Hadasit Med Res Service Use of ezetimibe and amiodarone in protection against beta-amyloid neurotoxicity
EP1865779A4 (en) * 2005-03-21 2008-06-04 Vicus Therapeutics Spe 1 Llc COMPOSITIONS AND METHODS FOR ENHANCING CACHEXIA
DE602006016934D1 (de) * 2005-04-06 2010-10-28 Adamas Pharmaceuticals Inc Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
EP1719507B1 (en) * 2005-04-13 2010-07-14 Astion Development A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
GB0519274D0 (en) * 2005-09-21 2005-11-02 Arakis Ltd The treatment of neurodegenerative diseases
GB0526123D0 (en) * 2005-12-22 2006-02-01 Univ Gent Synephrine derivatives useful as anti-inflammatory agents
GB0604822D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders and pain
GB0604824D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
EP2518049A2 (en) 2012-10-31
CN101573325A (zh) 2009-11-04
BRPI0720284A2 (pt) 2014-01-28
IL199178A0 (en) 2010-03-28
CA2672238A1 (en) 2008-06-19
JP5225287B2 (ja) 2013-07-03
WO2008071948A2 (en) 2008-06-19
KR20090088442A (ko) 2009-08-19
EP2118050A2 (en) 2009-11-18
ZA200903942B (en) 2010-08-25
WO2008071948A3 (en) 2008-07-31
JP2010512378A (ja) 2010-04-22
AU2007331337A1 (en) 2008-06-19
US20100076068A1 (en) 2010-03-25
MX2009006246A (es) 2009-07-16
EP2518049A3 (en) 2013-07-10
GB0624757D0 (en) 2007-01-17

Similar Documents

Publication Publication Date Title
RU2497807C2 (ru) Карбазольные соединения и терапевтические применения соединений
NO20092359L (no) Aminoalkoholderivater og deres terapeutiske anvendelse
CO6321269A2 (es) Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta 2 para el tratamiento de transtornos respiratorios
RU2015133171A (ru) Бензиламиновые производные
TW200745032A (en) Novel heterobicyclic derivatives
RU2007116038A (ru) Циклические диарилмочевины, используемые в качестве ингибиторов тирозинкиназы
ATE537169T1 (de) Piperidin- und piperazinderivate als p2x3- antagonisten
RU2006146070A (ru) Циннамидное соединение
ATE390415T1 (de) Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung
JP2010526129A5 (no)
SE0302487D0 (sv) Novel compounds
CO6311077A2 (es) Derivados de 1-(4-hidroxi-fenil)-1h-indol como ligandos novedosos de receptor de estrógeno
PE20090770A1 (es) Derivados de benzoxazolona
MX2009008465A (es) Nuevas 2-aminooxazolinas como ligandos de taar1.
NZ586082A (en) Indole compounds and methods for treating visceral pain
CO6260089A2 (es) Activadores de guanilato ciclasas solubles
MX2010006202A (es) Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
RS54700B1 (en) INDAZOLE DERIVATIVES SUBSTITUTED WITH BENZODIOXINIL
DE602005016775D1 (de) Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
PE20090606A1 (es) Nuevos inhibidores de catepsina c y uso
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
AR059328A1 (es) Derivados de antranilamida-2-amino-heteroareno-carboxamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y el uso de estos compuestos para la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por cetp
PE20090592A1 (es) Nuevos derivados de piperazina-amida
EA200801494A1 (ru) Производные оксадиазола с активностью crth2 рецептора
DE602004028902D1 (de) Triazinderivate als uv-absorber

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application